1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals in Russia

Pharmaceuticals in Russia

  • September 2016
  • -
  • MarketLine
  • -
  • 38 pages

Summary
Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia

Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
What was the size of the Russia pharmaceuticals market by value in 2015?

What will be the size of the Russia pharmaceuticals market in 2020?

What factors are affecting the strength of competition in the Russia pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitors in Russia's pharmaceuticals market?

Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The Russian pharmaceuticals market had total revenues of $16.9bn in 2015, representing a compound annual growth rate (CAGR) of 21.6% between 2011 and 2015.

The Russian market is largely controlled by the commercial segment, rather than government purchasing. In contrast, the majority of EU countries compensate 65-80 percent of patients' expenses incurred on purchasing most prescribed medicines, meaning that this section of the market is the driver. Coupled with this, Russia has much fewer active pharmacies than many of its European neighbours with double the number of patients per pharmacy, which indicates the capacity for growth.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 8% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $24.9bn by the end of 2020.

Table Of Contents

Pharmaceuticals in Russia
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Russia pharmaceuticals market value: $ billion, 2011-15
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Russia pharmaceuticals market share: % share, by value, 2015
Table 4: Russia pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Novartis AG: key facts
Table 10: Novartis AG: key financials ($)
Table 11: Novartis AG: key financial ratios
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: key financials ($)
Table 14: Pfizer Inc.: key financial ratios
Table 15: F. Hoffmann-La Roche Ltd: key facts
Table 16: F. Hoffmann-La Roche Ltd: key financials ($)
Table 17: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 18: F. Hoffmann-La Roche Ltd: key financial ratios
Table 19: Russia size of population (million), 2011-15
Table 20: Russia gdp (constant 2005 prices, $ billion), 2011-15
Table 21: Russia gdp (current prices, $ billion), 2011-15
Table 22: Russia inflation, 2011-15
Table 23: Russia consumer price index (absolute), 2011-15
Table 24: Russia exchange rate, 2011-15

List of Figures
Figure 1: Russia pharmaceuticals market value: $ billion, 2011-15
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Russia pharmaceuticals market share: % share, by value, 2015
Figure 4: Russia pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Russia, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Russia, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Russia, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2015
Figure 11: Bayer AG: revenues and profitability
Figure 12: Bayer AG: assets and liabilities
Figure 13: Novartis AG: revenues and profitability
Figure 14: Novartis AG: assets and liabilities
Figure 15: Pfizer Inc.: revenues and profitability
Figure 16: Pfizer Inc.: assets and liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues and profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.